Clinical Trial Update: Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating esmolol for myocardial protection in hypertrophic obstructive cardiomyopathy (HOCM).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Obstructive Cardiomyopathy

Drugs mentioned

• Esmolol (esmolol)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Hypertrophic Obstructive Cardiomyopathy | Phase 4 | Status: UNKNOWN